In our cohort, 45 out of 50 tumor tissues with decreased expression of MLH1 were available for testing for MLH1 promoter methylation, among which all but one sample exhibited the methylation in all 16 analyzed CpG positions. This evidence concerns the gene MLH1 and neoplasm.